Oct 07, 2016 13:30 pm UTC| Business
SAN FRANCISCO, Oct. 07, 2016 -- Hagens Berman Sobol Shapiro LLP reminds The Hain Celestial Group, Inc. (NASDAQ:HAIN) investors of the October 17, 2016 Lead Plaintiff deadline in the securities class action lawsuit filed...
Full House Resorts Announces Commencement of Rights Offering
Oct 07, 2016 13:27 pm UTC| Business
LAS VEGAS, Oct. 07, 2016 -- Full House Resorts, Inc. (NASDAQ:FLL) (the “Company”) announced today that it has commenced a $5,000,000 rights offering. The Company expects to distribute, at no charge, non-transferable...
THL Credit Schedules Third Fiscal Quarter 2016 Earnings Release and Conference Call
Oct 07, 2016 13:15 pm UTC| Business
BOSTON, Oct. 07, 2016 -- THL Credit, Inc. (NASDAQ:TCRD) ("THL Credit"), today announced that it will report its financial results for its third fiscal quarter of 2016 after the market closes on November 9, 2016. THL...
Oct 07, 2016 13:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 07, 2016 -- Global Blood Therapeutics, Inc.(GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with...
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Oct 07, 2016 13:04 pm UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., Oct. 07, 2016 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) (“Idera” or the “Company”) today announced the pricing of an underwritten public offering of 25,000,000 shares of common stock...
AxoGen Announces Pricing of Public Offering of Common Stock
Oct 07, 2016 13:00 pm UTC| Business
ALACHUA, Fla., Oct. 07, 2016 -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced the pricing of an underwritten public offering of 2,333,334...
Cidara Therapeutics Announces Pricing of Public Offering of Common Stock
Oct 07, 2016 13:00 pm UTC| Business
SAN DIEGO, Oct. 07, 2016 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing of an underwritten public offering of...